A single-arm phase IIIB study of pertuzumab and trastuzumab with a taxane as first-line therapy for patients with HER2-positive advanced breast cancer (peruse)

Category Primary study
JournalCancer Research
Year 2012
This article has no abstract
Epistemonikos ID: 542b561f0bf4d829bcb718440ee4af85003c5cfa
First added on: Feb 05, 2025